Oncol-话题@MedSci

#Oncol#

2384篇内容 | 2459人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1866709, encodeId=d9af1866e095a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Radiother Oncol：超脉冲CO2点阵激光联合30%超分子水杨酸能更好治疗痤疮疤痕, objectType=article, longId=738806, objectId=8d9ce38806e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d9ce38806e4, replyNumber=0, likeNumber=72, createdTime=2023-01-31, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d9ce38806e4, moduleTitle=Radiother Oncol：超脉冲CO2点阵激光联合30%超分子水杨酸能更好治疗痤疮疤痕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d9ce38806e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866619, encodeId=f0f61866619e7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子, objectType=article, longId=727960, objectId=4d1fe27960c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1fe27960c3, replyNumber=0, likeNumber=119, createdTime=2023-02-15, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1fe27960c3, moduleTitle=Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1fe27960c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866623, encodeId=1aa9186662316, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：雷莫芦单抗联合派姆单抗治疗晚期非小细胞肺癌, objectType=article, longId=728627, objectId=e0bce2862724, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bce2862724, replyNumber=0, likeNumber=55, createdTime=2022-09-24, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bce2862724, moduleTitle=J Clin Oncol：雷莫芦单抗联合派姆单抗治疗晚期非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0bce2862724)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866521, encodeId=fc3d186652155, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：III期临床研究XELAVIRI评估一线贝伐珠单抗为基础的续观治疗对比联合治疗转移性结直肠癌（mCRC）患者的疗效, objectType=article, longId=299336, objectId=5af529933624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5af529933624, replyNumber=0, likeNumber=141, createdTime=2022-10-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5af529933624, moduleTitle=Front Oncol：III期临床研究XELAVIRI评估一线贝伐珠单抗为基础的续观治疗对比联合治疗转移性结直肠癌（mCRC）患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5af529933624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866509, encodeId=42991866509fa, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点, objectType=article, longId=295661, objectId=5a7e29566140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a7e29566140, replyNumber=0, likeNumber=64, createdTime=2022-04-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a7e29566140, moduleTitle=Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a7e29566140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866626, encodeId=ded3186662676, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：FOLFOXIRI联合贝伐单抗±阿替利珠单抗治疗转移性结直肠癌, objectType=article, longId=728685, objectId=6d07e286855f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d07e286855f, replyNumber=0, likeNumber=101, createdTime=2023-01-20, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d07e286855f, moduleTitle=Lancet Oncol：FOLFOXIRI联合贝伐单抗±阿替利珠单抗治疗转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d07e286855f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866711, encodeId=f3801866e1109, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：儿童癌症幸存者后续发生心衰的风险和相关风险因素, objectType=article, longId=739399, objectId=97d8e3939957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97d8e3939957, replyNumber=0, likeNumber=98, createdTime=2023-03-03, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97d8e3939957, moduleTitle=J Clin Oncol：儿童癌症幸存者后续发生心衰的风险和相关风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97d8e3939957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866635, encodeId=6bbf18666356e, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：国产三代EGFR-TKI阿美替尼挺进晚期EGFR突变NSCLC患者一线治疗, objectType=article, longId=727759, objectId=e5e5e27759c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e5e27759c4, replyNumber=0, likeNumber=117, createdTime=2022-12-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e5e27759c4, moduleTitle=J Clin Oncol：国产三代EGFR-TKI阿美替尼挺进晚期EGFR突变NSCLC患者一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e5e27759c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866517, encodeId=1a58186651e61, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：卡培他滨维持治疗可明显改善转移性鼻咽癌患者的生存预后, objectType=article, longId=299226, objectId=14fc299226be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14fc299226be, replyNumber=0, likeNumber=74, createdTime=2022-07-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14fc299226be, moduleTitle=JAMA Oncol：卡培他滨维持治疗可明显改善转移性鼻咽癌患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14fc299226be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866693, encodeId=1dc01866693b5, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：新辅助治疗可提高早期直肠癌患者的肛门保留率, objectType=article, longId=736336, objectId=bf0fe363366b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf0fe363366b, replyNumber=0, likeNumber=113, createdTime=2022-10-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf0fe363366b, moduleTitle=J Clin Oncol：新辅助治疗可提高早期直肠癌患者的肛门保留率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf0fe363366b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866582, encodeId=4baf186658261, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后, objectType=article, longId=302272, objectId=31553022e20d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31553022e20d, replyNumber=0, likeNumber=74, createdTime=2022-08-23, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31553022e20d, moduleTitle=JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31553022e20d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866689, encodeId=add8186668959, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：化疗后采用鲁卡帕尼维持治疗DNA修复缺陷阳性转移性尿路上皮癌, objectType=article, longId=736046, objectId=9162e3604691, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9162e3604691, replyNumber=0, likeNumber=83, createdTime=2022-09-15, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9162e3604691, moduleTitle=J Clin Oncol：化疗后采用鲁卡帕尼维持治疗DNA修复缺陷阳性转移性尿路上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9162e3604691)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866647, encodeId=f079186664ef0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：恩杂鲁胺单药治疗可明显降低积极监测的中低危前列腺癌的进展率, objectType=article, longId=730184, objectId=4ac6e301848e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ac6e301848e, replyNumber=0, likeNumber=66, createdTime=2023-05-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ac6e301848e, moduleTitle=JAMA Oncol：恩杂鲁胺单药治疗可明显降低积极监测的中低危前列腺癌的进展率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ac6e301848e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866579, encodeId=654218665e9c6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：卡罗妥昔单抗联合帕唑帕尼治疗晚期血管肉瘤的疗效和安全性, objectType=article, longId=302293, objectId=2c1c3022933d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c1c3022933d, replyNumber=0, likeNumber=78, createdTime=2022-06-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c1c3022933d, moduleTitle=JAMA Oncol：卡罗妥昔单抗联合帕唑帕尼治疗晚期血管肉瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c1c3022933d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866712, encodeId=1c171866e1291, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：依托泊苷 vs 伊立替康联合顺铂治疗消化系统晚期神经内分泌癌, objectType=article, longId=739500, objectId=4a5ee3950072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a5ee3950072, replyNumber=0, likeNumber=79, createdTime=2023-03-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a5ee3950072, moduleTitle=JAMA Oncol：依托泊苷 vs 伊立替康联合顺铂治疗消化系统晚期神经内分泌癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a5ee3950072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866398, encodeId=cc031866398a0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响, objectType=article, longId=221553, objectId=243b2215533b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243b2215533b, replyNumber=0, likeNumber=118, createdTime=2022-10-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243b2215533b, moduleTitle=Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243b2215533b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866410, encodeId=765d1866410a7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：局部前列腺癌患者治疗遗憾的相关因素分析, objectType=article, longId=221336, objectId=78782213362f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78782213362f, replyNumber=0, likeNumber=94, createdTime=2021-12-14, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78782213362f, moduleTitle=JAMA Oncol：局部前列腺癌患者治疗遗憾的相关因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78782213362f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866492, encodeId=6df81866492bd, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncology：“烧死”肿瘤！科学家开发远程加热、磁性引导热种子的癌症新疗法, objectType=article, longId=295145, objectId=8de3295145dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8de3295145dc, replyNumber=0, likeNumber=86, createdTime=2023-01-02, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8de3295145dc, moduleTitle=JAMA Oncology：“烧死”肿瘤！科学家开发远程加热、磁性引导热种子的癌症新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8de3295145dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866642, encodeId=8bb9186664205, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：MRI引导的聚焦超声疗法治疗中危前列腺癌的疗效可期, objectType=article, longId=729829, objectId=0166e29829e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0166e29829e9, replyNumber=0, likeNumber=71, createdTime=2022-09-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0166e29829e9, moduleTitle=Lancet Oncol：MRI引导的聚焦超声疗法治疗中危前列腺癌的疗效可期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0166e29829e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866678, encodeId=447b18666e825, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法, objectType=article, longId=734317, objectId=5093e34317c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5093e34317c1, replyNumber=0, likeNumber=85, createdTime=2022-11-13, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5093e34317c1, moduleTitle=J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5093e34317c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Oncol

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Radiother Oncol：超脉冲CO2点阵激光联合30%超分子水杨酸能更好治疗痤疮疤痕

2023-01-31

docwu2019 (审核中...)

前往app查看评论内容

#Oncol#

Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子

2023-02-15

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：雷莫芦单抗联合派姆单抗治疗晚期非小细胞肺癌

2022-09-24

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：III期临床研究XELAVIRI评估一线贝伐珠单抗为基础的续观治疗对比联合治疗转移性结直肠癌（mCRC）患者的疗效

2022-10-25

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点

2022-04-09

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：FOLFOXIRI联合贝伐单抗±阿替利珠单抗治疗转移性结直肠癌

2023-01-20

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：儿童癌症幸存者后续发生心衰的风险和相关风险因素

2023-03-03

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：国产三代EGFR-TKI阿美替尼挺进晚期EGFR突变NSCLC患者一线治疗

2022-12-09

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：卡培他滨维持治疗可明显改善转移性鼻咽癌患者的生存预后

2022-07-09

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：新辅助治疗可提高早期直肠癌患者的肛门保留率

2022-10-25

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后

2022-08-23

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：化疗后采用鲁卡帕尼维持治疗DNA修复缺陷阳性转移性尿路上皮癌

2022-09-15

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：恩杂鲁胺单药治疗可明显降低积极监测的中低危前列腺癌的进展率

2023-05-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：卡罗妥昔单抗联合帕唑帕尼治疗晚期血管肉瘤的疗效和安全性

2022-06-22

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：依托泊苷 vs 伊立替康联合顺铂治疗消化系统晚期神经内分泌癌

2023-03-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响

2022-10-18

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：局部前列腺癌患者治疗遗憾的相关因素分析

2021-12-14

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncology：“烧死”肿瘤！科学家开发远程加热、磁性引导热种子的癌症新疗法

2023-01-02

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：MRI引导的聚焦超声疗法治疗中危前列腺癌的疗效可期

2022-09-06

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法

2022-11-13

科室
- - 订阅+
  - 更多科室
工具
服务